Back to search
Heart Failure, Left Sided
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Heart Failure, Left Sided trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Heart Failure, Left Sided trials you may qualify forThis study aims to compare the efficacy of vericiguat versus placebo on change in n-terminal pro-brain natriuretic peptide (NTproBNP) from baseline to Week 16 o…
Heart failure is a severe disease affecting approximately 1-2% of the adult population in developed countries and around 26 million people worldwide. Up to 10%…
Finerenone will be compared to placebo to determine efficacy and safety of treatment in patients hospitalized with acute decompensated heart failure (HF) and mi…
The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥…
Background There are significant limitations in the current approaches to assessing 2 important areas of cardiovascular physiology - the systemic circulation an…
This study will compare two different methods to pace the heart to treat heart failure including: 1. The current standard method of implanting a pacing lead in…
The main purpose of this study is to observe outcomes of sodium-glucose co-transporter 2 inhibitors (SGLT2i) in heart failure (HF) patients with left ventricula…
Primary Objective - To determine if implantation of a permanent CRT pacing device (with LB-CRT, or conventional BiV-CRT with a coronary sinus LV lead) can impro…
Mitral valve leakage, or mitral regurgitation (MR), is associated with heart failure symptoms including shortness of breath, fatigue, irregular heart rate. When…